| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| GTO ID | GTC3046 |
| Trial ID | NCT05393986 |
| Disease | Gastroesophageal Adenocarcinoma | Gastric Adenocarcinoma | Pancreatic Cancer |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CT048 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | Peking University |
| Other ID(s) | CT048-CG4001 |
| Cohort 1 | |||||||||||
|
|||||||||||